Holdco Nuvo Group DG Stock Quote NUVO - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.9722

Bid

0.9504

Ask

1.00

Volume

0.00 Day's Range 0.00

0.90 52 Week Range 8.25

Market Cap

32.337M

Previous Close

0.9722

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

959,577

Shares Outstanding

33,261,549

Dividend Yield

PE Ratio

-6.04

Earnings Per Share (EPS)

-0.16

Revenue

Net Profit

-5.34M

Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo¿s INVU¿ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of rem... Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo¿s INVU¿ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring, while pioneering new data-driven personalized pathways that can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo will continue to expand the footprint of sales in the US and Israel and plans to introduce the product in Europe in 2024 following the hoped for granting of the CE mark in 2024 to provide remote access and insights not previously deemed possible. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.arcabio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Holdco Nuvo Group DG Ltd is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker NUVO. The last closing price for Holdco Nuvo Group DG was $0.97. Over the last year, Holdco Nuvo Group DG shares have traded in a share price range of $ 0.90 to $ 8.25.

Holdco Nuvo Group DG currently has 33,261,549 shares outstanding. The market capitalization of Holdco Nuvo Group DG is $32.34 million. Holdco Nuvo Group DG has a price to earnings ratio (PE ratio) of -6.04.

Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care

TEL AVIV, Israel, May 09, 2024 (GLOBE NEWSWIRE) -- Holdco Nuvo Group D.G Ltd (NASDAQ: NUVO) (“Nuvo”), a pioneer in remote pregnancy monitoring, today announced the expansion of its board of...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1527	-13.5745399591	1.1249	1.15	0.9	29196	0.99092796	CS
4	-0.4778	-32.9517241379	1.45	1.48	0.9	38272	1.09300374	CS
12	-5.3278	-84.5682539683	6.3	8.25	0.9	959577	4.6419897	CS
26	-5.3278	-84.5682539683	6.3	8.25	0.9	959577	4.6419897	CS
52	-5.3278	-84.5682539683	6.3	8.25	0.9	959577	4.6419897	CS
156	-5.3278	-84.5682539683	6.3	8.25	0.9	959577	4.6419897	CS
260	-5.3278	-84.5682539683	6.3	8.25	0.9	959577	4.6419897	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DRMADermata Therapeutics Inc	$ 4.09 (214.62%)	5.1M
NUZENuZee Inc	$ 1.77 (71.84%)	1.33M
RGCRegencell Bioscience Holdings Ltd	$ 22.10 (47.73%)	302.62k
ALLRAllarity Therapeutics Inc	$ 0.2442 (46.67%)	19.13M
NIVFNewGenIvf Group Ltd	$ 1.13 (29.75%)	1.64M
CONNConns Inc	$ 0.3287 (-35.17%)	78.81k
VSTMVerastem Inc	$ 2.62 (-27.02%)	33.77k
ATPCAgape ATP Corporation	$ 0.172 (-20.00%)	214.99k
SLRXSalarius Pharmaceuticals Inc	$ 2.10 (-19.54%)	41.63k
ALPPAlpine 4 Holdings Inc	$ 0.4859 (-19.00%)	28.51k
ALLRAllarity Therapeutics Inc	$ 0.2461 (47.81%)	19.13M
SLNASelina Hospitality PLC	$ 0.0279 (7.31%)	7.52M
DRMADermata Therapeutics Inc	$ 3.99 (206.92%)	5.1M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 11.67 (-14.82%)	2.12M
NIVFNewGenIvf Group Ltd	$ 1.12 (28.60%)	1.64M